Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Voss

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
Medicine|March 2, 2023
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysisAgustín Ciapponi, Mabel Berrueta, Jamile Ballivian, et al.
Plos One|May 12, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African AdultsGloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid reviewAgustín Ciapponi, Ariel Bardach, Agustina Mazzoni, et al.
Vaccine|September 7, 2021
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid reviewAgustín Ciapponi, Ariel Bardach, Agustina Mazzoni, et al.
Journal of Virology|May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineagesM Anthony Moody, Nicole L Yates, Joshua D Amos, et al.
Plos One|July 7, 2015
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve AdultsChristian F Ockenhouse, Jason Regules, Donna Tosh, et al.
The Journal of Experimental Medicine|October 12, 2011
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedHua-Xin Liao, Xi Chen, Supriya Munshaw, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
Medicine|March 2, 2023
Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysisAgustín Ciapponi, Mabel Berrueta, Jamile Ballivian, et al.
Plos One|May 12, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African AdultsGloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Safety of COVID-19 vaccines, their components or their platforms for pregnant women: A rapid reviewAgustín Ciapponi, Ariel Bardach, Agustina Mazzoni, et al.
Vaccine|September 7, 2021
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid reviewAgustín Ciapponi, Ariel Bardach, Agustina Mazzoni, et al.
Journal of Virology|May 4, 2012
HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineagesM Anthony Moody, Nicole L Yates, Joshua D Amos, et al.
Plos One|July 7, 2015
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve AdultsChristian F Ockenhouse, Jason Regules, Donna Tosh, et al.
The Journal of Experimental Medicine|October 12, 2011
Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedHua-Xin Liao, Xi Chen, Supriya Munshaw, et al.
Science (New York, N.Y.)|July 4, 2015
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeysDan H Barouch, Galit Alter, Thomas Broge, et al.
Pageof 5